Teva Pharmaceutical Industries Ltd (TEVA)
$10.53 0.32 (3.13%)
6:26 EST TEVA Stock Quote Delayed 15 Minutes
Previous Close $10.25
Market Cap 10.72B
PE Ratio -0.67
Volume (Avg. Vol.) 65,611
Day's Range 10.21 - 10.21
52-Week Range 6.07 - 20.21
Dividend & Yield 0.07 (0.68%)
TEVA Stock Predictions, Articles, and Teva Pharmaceutical Industries Ltd News
- From InvestorPlace
- From the Web
Teva can handle its debt and deal with its liability from the opioid tragedy. And Teva stock has multiple, positive catalysts.
Suffering from many missteps, generics drugmaker Teva is still struggling to heal. Here's what to expect from TEVA stock in 2020.
Teva stock has been a long-term loser, but there are signs that things are starting to turn around. Should investors consider it in 2020?
While Schulz's cost-cutting has reduced Teva's debt by more than $8 billion, more needs to be done to bolster the company's balance sheet.
Teva's debt restructuring gives it breathing room through 2021, assuming its legal woes don't get worse. Buy Teva stock at your own risk.
Lately, Teva stock has had a nice rally, but this may prove temporary. The fact is that the company faces much uncertainty with the litigation.
A portfolio should hold high-risk, high-reward plays. And these nine stocks to buy offer big risks and even bigger potential returns.
By Thomas Niel
With shares rebounded, now may not be the time to enter Teva stock. Wait to see how upcoming opioid trials play out. If shares pull back to prior price levels, a buying opportunity may emerge. But for now, the risks do not match up with potential upside.
Teva stock has rallied from its lows on optimism toward legal settlements. But the balance sheet of TEVA remains an enormous risk.
Teva Pharmaceuticals is under the glare of legal and regulatory scrutiny. However, TEVA will eventually find its way because frankly, it has to.
For risk-averse investors, TEVA stock has many questions that make it a rough pick. But for the hardened speculator, it might be worth a shot.
By David Moadel
TEVA stock has earned its reputation - and I mean that in the worst possible way.
The U.S.-China trade war is weighing on these large-cap stocks to sell. Volatile oil prices and the opioid crisis aren't helping, either.
Despite the rally, Teva stock is inexpensive. The company is working on paying off its debt and building a strong generics portfolio.
Palo Alto Networks, Burlington Stores, Teva and Disney are our top stock trades to watch going into Wednesday.
Over the past year, healthcare stocks generally lagged as markets rebounded. That's changing though, starting with these three names.
By Thomas Niel
The TEVA stock price has rebounded on a potential opioid settlement. But consider the company's other risks before buying Teva.
Teva stock fell sharply this year in large part thanks to the opioid crisis, but with a last-minute deal, shares look more interesting now.
Navellier RatingsPowered by Portfolio Grader